Page last updated: 2024-11-06

valerophenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Valerophenone is a synthetic ketone compound that has been investigated for its potential medicinal properties, particularly as an anticonvulsant agent. It is synthesized via the Friedel-Crafts acylation of benzene with valeryl chloride in the presence of a Lewis acid catalyst. Studies have shown that valerophenone exhibits anticonvulsant activity in animal models, potentially by interacting with GABAergic neurotransmission. This compound is of interest for its potential to treat neurological disorders, such as epilepsy, however, further research is needed to determine its safety and efficacy in humans. '

Cross-References

ID SourceID
PubMed CID66093
CHEMBL ID372105
CHEBI ID36812
SCHEMBL ID50014
MeSH IDM0543903

Synonyms (44)

Synonym
1-phenylpentan-1-one
pentanophenone
CHEBI:36812 ,
1-phenyl-1-pentanone
nsc-58959
valerophenone ,
butyl phenyl ketone
nsc58959
1-pentanone, 1-phenyl-
1009-14-9
valerophenone, 99%
inchi=1/c11h14o/c1-2-3-9-11(12)10-7-5-4-6-8-10/h4-8h,2-3,9h2,1h3
xkglskvnoshtad-uhfffaoysa-
CHEMBL372105
FT-0657901
V0009
AKOS000120679
unii-f27q043nt1
ai3-09309
einecs 213-767-3
nsc 58959
f27q043nt1 ,
1-phenyl-pentan-1-one
BBL011454
n-butyl phenyl ketone
FT-0675759
STL146566
AM20020075
SCHEMBL50014
DTXSID0061406
W-108931
mfcd00009480
F0001-0049
1-benzoylbutane
valerophenone, 8ci
SY013718
Q3304162
4-methyl butyrophenone
AS-12867
EN300-21000
AC8072
A897297
CS-W010853
1-phenylpentan-1-one, butyl phenyl ketone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1519674Chromatographic hydrophobicity index of compound at 250 uM at pH 7.4 by HPLC analysis2020European journal of medicinal chemistry, Jan-01, Volume: 185Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies.
AID1519676Retention time of compound at pH 7.4 by LC-UV analysis2020European journal of medicinal chemistry, Jan-01, Volume: 185Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies.
AID236904Partition coefficient (logP)2005Bioorganic & medicinal chemistry letters, Jul-01, Volume: 15, Issue:13
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.02 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index56.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]